These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9484287)

  • 1. Age-related macular degeneration: how science is improving clinical care. Interview by Marc E. Weksler.
    Sunness JS
    Geriatrics; 1998 Feb; 53(2):70-4, 77-80. PubMed ID: 9484287
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmology quiz #4: age related macular degeneration.
    Hagen JC
    Mo Med; 1994 Apr; 91(4):169-70. PubMed ID: 7515461
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can laser photocoagulation of eyes with high-risk drusen prevent vision loss from age-related macular degeneration?
    Folk JC; Russell SR
    Ophthalmology; 1999 Jul; 106(7):1241-2. PubMed ID: 10406600
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subretinal neovascular membrane in age-related macular degeneration].
    Budzinskaia MV; Gurova IV
    Vestn Oftalmol; 2006; 122(4):49-54. PubMed ID: 16927789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Age related macular degeneration as a cause of blindness].
    Starzycka M; Słomska J
    Klin Oczna; 1997; 99(4):253-5. PubMed ID: 9577117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
    Complications of Age-Related Macular Degeneration Prevention Trial Research Group
    Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complex diagnosis of the early macular changes due to AMD].
    Kwiecień S; Szaflik JP; Szaflik J
    Klin Oczna; 2007; 109(4-6):209-13. PubMed ID: 17725289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imaging of type I idiopathic macular telangiectasia associated with age-related macular degeneration (ARMD)].
    Lupei I; Cudraz I; Mauget-Faÿsse M
    J Fr Ophtalmol; 2010 Jun; 33(6):430-1. PubMed ID: 20493582
    [No Abstract]   [Full Text] [Related]  

  • 11. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M;
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age related macular degeneration and subretinal neovessels. Primary cause of acquired blindness in adults in France].
    Coscas G
    Rev Prat; 1991 Nov; 41(23):2320-2. PubMed ID: 1792495
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-related macular degeneration: legal vs total blindness.
    Pinsky N
    Can Fam Physician; 1997 May; 43():841. PubMed ID: 9154352
    [No Abstract]   [Full Text] [Related]  

  • 14. Senile disciform macular degeneration.
    Br Med J; 1979 Jun; 1(6176):1444-5. PubMed ID: 572726
    [No Abstract]   [Full Text] [Related]  

  • 15. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity.
    Boon CJ; Theelen T; Hoyng CB
    Am J Ophthalmol; 2009 Jul; 148(1):173-4; author reply 174-5. PubMed ID: 19540988
    [No Abstract]   [Full Text] [Related]  

  • 16. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity.
    Hamel CP; Meunier I; Arndt C; Ben Salah S; Lopez S; Bazalgette C; Bazalgette C; Zanlonghi X; Arnaud B; Defoort-Dellhemmes S; Puech B
    Am J Ophthalmol; 2009 Apr; 147(4):609-20. PubMed ID: 19181301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early features of AMD.
    Hogg RE; Stevenson MR; Chakravarthy U; Beirne RO; Anderson RS
    Ophthalmology; 2007 May; 114(5):1028. PubMed ID: 17467536
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium on age-related macular degeneration.
    Yannuzzi LA; Friedman R; Fine SL; Gass JD; Gitter KA; Orth DH; Singerman LJ
    Bull N Y Acad Med; 1988 Dec; 64(9):955-1013. PubMed ID: 3077076
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in the drusenoid retinal pigment epithelium detachment area in the dry form of age-related macular degeneration 2.5 years after rheohemapheresis.
    Rencová E; Bláha M; Studnička J; Bláha V; Brožík J; Pazderová M; Rozsíval P; Langrová H
    Acta Ophthalmol; 2013 Aug; 91(5):e406-8. PubMed ID: 22971248
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of highly myopic eyes: the Beijing Eye Study.
    Xu L; Li Y; Wang S; Wang Y; Wang Y; Jonas JB
    Ophthalmology; 2007 Jan; 114(1):121-6. PubMed ID: 17070594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.